Filter by: patients
Home > Community Treatment Reports and Side Effects > Ogen Treatment Report
What is Ogen?

Ogen® is a brand name for estropipate, an estrogen derivative. It is used to treat moderate to severe vasomotor symptoms associated with menopause; treatment of vulvar and vaginal atrophy; hypoestrogenism; and for the prevention of osteoporosis in high risk women.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 1 1 Efficacy_moderate

See 1 patient currently taking Ogen

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 2

Reported Dosages

  0.065 mg daily
  1 Number of Patients: 1  

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Ogen

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Ogen

Always
 2 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Ogen

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 2 100%

Cost

Paid out of pocket

Cost of Ogen

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 2 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.